A Task Force supported by the European Respiratory Society has developed this guideline to provide evidence-based recommendations on diagnostic testing, especially in light of new developments in such tests, and the need for robust diagnoses of patients who might enter randomised controlled trials of treatments.
Mesothelioma is a rare type of lung cancer, typically caused by Asbestos inhalation and commonly...
The GIRFT Tuberculosis (TB) report is a comprehensive, data-driven national review of TB services...
In 2020 the COVID-19 pandemic hit the global population, causing lockdowns and economic...
This guideline covers diagnosing, assessing, and treating community-acquired and hospital-acquired...
COPD is the second most common cause for hospital admission and the third leading cause of death...